Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 24
Phase 32

Trial Status

Completed3
Terminated2

Role Distribution

Other Roles5

Activity Timeline

Clinical Trials (5)

NCT00258739Phase 2Completed
Docetaxel in Non Small Cell Lung Cancer (NSCLC)
Lung Neoplasms
Studydirector
NCT00259363Phase 1/2Terminated
Oxaliplatin in Rectal Cancer
Rectal Neoplasms
Studydirector
NCT00259402Phase 2Completed
Oxaliplatin in Esophagus Cancer (Advanced) 1st Line
Esophageal Neoplasms
Studydirector
NCT00261703Phase 2/3Completed
Docetaxel in Head and Neck Cancer
Head and Neck Neoplasms
Studydirector
NCT00458081Phase 3Terminated
Evaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk Factors
Diabetes Mellitus, Type 2DyslipidemiaMicroalbuminuria+1 more
Studydirector

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT00258739Phase 2StudyDirector

Docetaxel in Non Small Cell Lung Cancer (NSCLC)

Lung Neoplasms
Completed
NCT00259363Phase 1/2StudyDirector

Oxaliplatin in Rectal Cancer

Rectal Neoplasms
Terminated
NCT00259402Phase 2StudyDirector

Oxaliplatin in Esophagus Cancer (Advanced) 1st Line

Esophageal Neoplasms
Completed
NCT00261703Phase 2/3StudyDirector

Docetaxel in Head and Neck Cancer

Head and Neck Neoplasms
Completed
NCT00458081Phase 3StudyDirector

Evaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk Factors

Diabetes Mellitus, Type 2DyslipidemiaMicroalbuminuria+1 more
Terminated

All 5 trials loaded